| Ex. AGY-FED-HEALTH-OTHER-014 | DEA-DC-022 (DEA068), letter permitting DATA-waived practitioners to prescribe buprenorphine to new patients on the basis of a telephone evaluation during the COVID-19 emergencyDEA/SAMHSA Buprenorphine Telemedicine (Final) | Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA | United States (federal); Drug Enforcement Administration, Diversion Control Division (with SAMHSA)Federal | Mar. 31, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Telework mandateHealth care ordersOther | Primary source read | |
| Ex. AGY-FED-HEALTH-OTHER-015 | DEA-DC-023 (DEA075), How to Prescribe Controlled Substances to Patients During the COVID-19 Public Health Emergency (decision tree)How to Prescribe Controlled Substances to Patients During the COVID-19 Public Health Emergency | Drug Enforcement Administration, Diversion Control Division | United States (federal); Drug Enforcement Administration, Diversion Control DivisionFederal | Mar. 31, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Telework mandateHealth care ordersOther | Primary source read | |
| Ex. FED-090 | CMS-1744-IFC, Medicare and Medicaid Programs; Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency (interim final rule with comment period)Medicare and Medicaid Programs; Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency, 85 Fed. Reg. 19230… | Centers for Medicare & Medicaid Services, HHS | United States (Medicare and Medicaid providers)Federal | Mar. 30, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Health care ordersOther | Primary source read | |
| Ex. SEC-02-006 | CMS-1744-IFC, Medicare and Medicaid Programs; Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency, 85 Fed. Reg. 19230Telehealth expansion (home as originating site; added services; audio-only codes; virtual direct supervision) | CMS | United StatesFederal | Apr. 6, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Health care ordersOther | Primary source read | |
| Ex. AGY-FED-HEALTH-OTHER-002 | Enforcement Discretion Under HIPAA To Allow Uses and Disclosures of Protected Health Information by Business Associates for Public Health and Health Oversight Activities in Response to COVID-19, 85 Fed. Reg. 19392 (Apr. 7, 2020)Enforcement Discretion Under HIPAA To Allow Uses and Disclosures of Protected Health Information by Business Associates for Public Health… | Roger T. Severino, Director, Office for Civil Rights, HHS | United States (federal); Department of Health and Human Services, Office for Civil RightsFederal | Apr. 2, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Health care ordersOther | Primary source read | |
| Ex. AGY-FED-LABOR-IMMIGRATION-016 | Memorandum, Enforcement Guidance for Respiratory Protection and the N95 Shortage Due to the Coronavirus Disease 2019 (COVID-19) Pandemic (Apr. 3, 2020)Enforcement Guidance for Respiratory Protection and the N95 Shortage Due to the Coronavirus Disease 2019 (COVID-19) Pandemic | OSHA Directorate of Enforcement Programs to Regional Administrators and State Plan Designees | United States Department of Labor, OSHA (federal agency)Federal | Apr. 3, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q2 | Health care ordersWorkplace rulesSupply chain | Primary source read | |
| Ex. AGY-AVIATION-SURFACE-045 | DOT COVID-19 Drug & Alcohol Testing Statement of Enforcement Discretion for Substance Abuse Professionals and Service Agents (Apr. 4, 2020)DOT COVID-19 Drug & Alcohol Testing Statement of Enforcement Discretion for Substance Abuse Professionals and Service Agents | U.S. Department of Transportation, Office of Drug and Alcohol Policy and Compliance (ODAPC) | United States (U.S. Department of Transportation, Office of Drug and Alcohol Policy and Compliance; all DOT-regulated employers in aviation, trucking, rail, transit, pipelines and maritime)Federal | Apr. 4, 2020 | 2020 Q2 | Context (guidance or announcement)Health care ordersWorkplace rulesOther | Primary source read | |
| Ex. AGY-FED-HEALTH-OTHER-016 | DEA-DC-025 (DEA078), Dear Registrant letter permitting opioid treatment programs to use the same off-site location repeatedly to deliver take-home methadone doses without separate registrationOff-site OTP delivery method (Final) | Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA | United States (federal); Drug Enforcement Administration, Diversion Control DivisionFederal | Apr. 7, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Health care ordersOther | Primary source read | |
| Ex. FED-158 | CMS, Non-Emergent, Elective Medical Services, and Treatment Recommendations (Apr. 7, 2020) (tiered framework; supplements the Adult Elective Surgery and Procedures Recommendations of Mar. 18, 2020)Non-Emergent, Elective Medical Services, and Treatment Recommendations | Centers for Medicare & Medicaid Services, HHS | United States (all healthcare facilities and clinicians)Federal | Apr. 7, 2020 | 2020 Q2 | Business closureHealth care orders | Primary source read | |
| Ex. SEC-01-008 | Non-Emergent, Elective Medical Services, and Treatment RecommendationsNon-Emergent, Elective Medical Services, and Treatment Recommendations (tiered framework) | CMS | United StatesFederal | Apr. 7, 2020 | 2020 Q2 | Health care orders | Primary source read | |
| Ex. AGY-FED-HEALTH-OTHER-003 | Enforcement Discretion Regarding COVID-19 Community-Based Testing Sites (CBTS) During the COVID-19 Nationwide Public Health Emergency, 85 Fed. Reg. 29637 (May 18, 2020)Enforcement Discretion Regarding COVID-19 Community-Based Testing Sites (CBTS) During the COVID-19 Nationwide Public Health Emergency | Roger T. Severino, Director, Office for Civil Rights, HHS | United States (federal); Department of Health and Human Services, Office for Civil RightsFederal | Apr. 9, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Health care ordersOther | Primary source read | |
| Ex. AGY-FED-HEALTH-OTHER-053 | Emergency Use Authorization: Face Shields (umbrella) (issued Apr. 9, 2020; amended Apr. 13, 2020)Letter of Authorization, Face Shields (Apr. 13, 2020) | Denise M. Hinton, Chief Scientist, FDA | United States (federal); Food and Drug AdministrationFederal | Apr. 13, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Health care ordersSupply chain | Primary source read | |
| Ex. AGY-FED-HEALTH-OTHER-018 | DEA-DC-028 (DEA084), letter permitting DEA-registered hospitals and clinics to handle controlled substances at satellite locations under the existing registration during the COVID-19 emergencyHospital/Clinic Registration Exception (final) | William T. McDermott, Assistant Administrator, Diversion Control Division, DEA | United States (federal); Drug Enforcement Administration, Diversion Control DivisionFederal | Apr. 10, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Health care ordersOther | Primary source read | |
| Ex. AGY-FED-HEALTH-OTHER-118 | Provider Relief Fund, Acceptance of Terms and Conditions, Relief Fund Payment from Initial $30 Billion General DistributionAcceptance of Terms and Conditions - Relief Fund Payment from Initial $30 Billion General Distribution | Secretary of Health and Human Services (terms administered by HRSA) | United States (federal); Department of Health and Human Services (Health Resources and Services Administration administering the Provider Relief Fund)Federal | Apr. 10, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Health care ordersOther | Primary source read | |
| Ex. AGY-FED-HEALTH-OTHER-019 | DEA-DC-029 (DEA085), letter granting a temporary exception to the five percent rule for practitioners distributing controlled substances to other registrants during the COVID-19 emergencyDEA 5 percent practitioner exception (final) | William T. McDermott, Assistant Administrator, Diversion Control Division, DEA | United States (federal); Drug Enforcement Administration, Diversion Control DivisionFederal | Apr. 13, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Health care ordersSupply chainOther | Primary source read | |
| Ex. AGY-FED-LABOR-IMMIGRATION-020 | Memorandum, Interim Enforcement Response Plan for Coronavirus Disease 2019 (COVID-19) (Apr. 13, 2020)Interim Enforcement Response Plan for Coronavirus Disease 2019 (COVID-19) | OSHA Directorate of Enforcement Programs (Patrick J. Kapust) to Regional Administrators and State Plan Designees | United States Department of Labor, OSHA (federal agency)Federal | Apr. 13, 2020 | 2020 Q2 | Health care ordersWorkplace rules | Primary source read | |
| Ex. FED-159 | CMS Recommendations, Re-opening Facilities to Provide Non-emergent Non-COVID-19 Healthcare: Phase I (Apr. 19, 2020)Opening Up America Again: Centers for Medicare & Medicaid Services (CMS) Recommendations Re-opening Facilities to Provide Non-emergent… | Centers for Medicare & Medicaid Services, HHS | United StatesFederal | Apr. 19, 2020 | 2020 Q2 | Capacity limitHealth care ordersWorkplace rules | Primary source read | |
| Ex. SEC-01-009 | Re-opening Facilities to Provide Non-emergent Non-COVID-19 Healthcare: Phase ICMS Recommendations: Re-opening Facilities to Provide Non-emergent Non-COVID-19 Healthcare: Phase I | CMS | United StatesFederal | Apr. 19, 2020 | 2020 Q2 | Health care orders | Primary source read | |
| Ex. AGY-DEFENSE-GUARD-127 | I Corps & JBLM COVID-19 Response Factsheet, Update 13 (as of Apr. 21, 2020)I Corps & JBLM COVID-19 Response Factsheet (Update 13) | I Corps and Joint Base Lewis-McChord | Joint Base Lewis-McChord, WashingtonFederal | Apr. 21, 2020 | 2020 Q2 | Context (guidance or announcement)Business closureGathering capFace-covering requirementTravel and quarantineSchools and child careHealth care orders | Primary source read | |
| Ex. AGY-FED-HEALTH-OTHER-020 | DEA-DC-030 (DEA087), letter extending the off-site take-home delivery flexibility to buprenorphine dispensed by opioid treatment programsOff site OTP delivery buprenorphine | Thomas W. Prevoznik, Deputy Assistant Administrator, Diversion Control Division, DEA | United States (federal); Drug Enforcement Administration, Diversion Control DivisionFederal | Apr. 21, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Health care ordersOther | Primary source read | |
| Ex. AGY-FED-HEALTH-OTHER-025 | FAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergencyFAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergency | SAMHSA, Center for Substance Abuse Treatment, Division of Pharmacologic Therapies | United States (federal); Department of Health and Human Services, Substance Abuse and Mental Health Services AdministrationFederal | Apr. 21, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Context (guidance or announcement)Health care ordersOther | Primary source read | |
| Ex. AGY-FED-LABOR-IMMIGRATION-022 | Memorandum, Enforcement Guidance on Decontamination of Filtering Facepiece Respirators in Healthcare During the COVID-19 Pandemic (Apr. 24, 2020)Enforcement Guidance on Decontamination of Filtering Facepiece Respirators in Healthcare During the Coronavirus Disease 2019 (COVID-19)… | OSHA Directorate of Enforcement Programs | United States Department of Labor, OSHA (federal agency)Federal | Apr. 24, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q2 | Health care ordersWorkplace rulesSupply chain | Primary source read | |
| Ex. AGY-AVIATION-SURFACE-023 | Exemption No. 18537, Regulatory Docket FAA-2020-0412, partial grant of the Air Medical Operators Association's petitionExemption 18537: COVID-19 relief from recurrent training and testing timeframes for air ambulance (helicopter and airplane) personnel | Federal Aviation Administration, Aviation Safety | United States (Federal Aviation Administration)Federal | May 1, 2020 | 2020 Q22020 Q3 | Health care ordersWorkplace rulesOther | Primary source read | |
| Ex. DUT-FED-023 | 42 C.F.R. 483.80 (infection control; COVID-19 reporting; COVID-19 testing)§ 483.80 Infection control | Centers for Medicare & Medicaid Services (condition of participation for long-term care facilities) | United StatesFederal | Oct. 4, 2016 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Standing dutyHealth care ordersWorkplace rulesVaccination or testingStanding duty | Primary source read | |
| Ex. FED-091 | CMS-5531-IFC, Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency (interim final rule)Medicare and Medicaid Programs, Basic Health Program, and Exchanges; Additional Policy and Regulatory Revisions in Response to the COVID-19… | Centers for Medicare & Medicaid Services, HHS | United StatesFederal | May 1, 2020 | 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3 | Health care ordersOther | Primary source read | |